| The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis Y Zhang, B Heym, B Allen, D Young, S Cole Nature 358 (6387), 591-593, 1992 | 1869 | 1992 |
| Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus A Scorpio, Y Zhang Nature medicine 2 (6), 662-667, 1996 | 1029 | 1996 |
| Mechanisms of Drug Resistance in Mycobacterium tuberculosis Y Zhang, C Vilchèze, WR Jacobs JR Tuberculosis and the tubercle bacillus, 115-140, 2004 | 897 | 2004 |
| The curious characteristics of pyrazinamide: a review Y Zhang, D Mitchison The international journal of tuberculosis and lung disease 7 (1), 6-21, 2003 | 876 | 2003 |
| Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance J Zhou, J Wulfkuhle, H Zhang, P Gu, Y Yang, J Deng, JB Margolick, ... Proceedings of the National Academy of Sciences 104 (41), 16158-16163, 2007 | 800 | 2007 |
| Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis W Shi, X Zhang, X Jiang, H Yuan, JS Lee, CE Barry 3rd, H Wang, ... Science 333 (6049), 1630-1632, 2011 | 707 | 2011 |
| Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid Y Zhang, MM Wade, A Scorpio, H Zhang, Z Sun Journal of antimicrobial chemotherapy 52 (5), 790-795, 2003 | 695 | 2003 |
| The magic bullets and tuberculosis drug targets Y Zhang Annu. Rev. Pharmacol. Toxicol. 45 (1), 529-564, 2005 | 661 | 2005 |
| Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis A Scorpio, P Lindholm-Levy, L Heifets, R Gilman, S Siddiqi, M Cynamon, ... Antimicrobial agents and chemotherapy 41 (3), 540-543, 1997 | 476 | 1997 |
| Role of Acid pH and Deficient Efflux of Pyrazinoic Acid in Unique Susceptibility of Mycobacterium tuberculosis to Pyrazinamide Y Zhang, A Scorpio, H Nikaido, Z Sun Journal of bacteriology 181 (7), 2044-2049, 1999 | 424 | 1999 |
| Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis Z Song, L Marzilli, BM Greenlee, ES Chen, RF Silver, FB Askin, ... The Journal of experimental medicine 201 (5), 755-767, 2005 | 415 | 2005 |
| Mechanisms of pyrazinamide action and resistance Y Zhang, W Shi, W Zhang, D Mitchison Microbiology spectrum 2 (4), 10.1128/microbiolspec. mgm2-0023-2013, 2014 | 350 | 2014 |
| The immunology of tuberculosis: from bench to bedside K Dheda, SK Schwander, B Zhu, RN van Zyl‐Smit, Y Zhang Respirology 15 (3), 433-450, 2010 | 335 | 2010 |
| Targeting persisters for tuberculosis control Y Zhang, WW Yew, MR Barer Antimicrobial agents and chemotherapy 56 (5), 2223-2230, 2012 | 332 | 2012 |
| Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms S Sreevatsan, XI Pan, Y Zhang, BN Kreiswirth, JM Musser Antimicrobial agents and chemotherapy 41 (3), 636-640, 1997 | 322 | 1997 |
| Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549 X Yin, J Zhou, C Jie, D Xing, Y Zhang Life sciences 75 (18), 2233-2244, 2004 | 316 | 2004 |
| Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis B Heym, Y Zhang, S Poulet, D Young, ST Cole Journal of bacteriology 175 (13), 4255-4259, 1993 | 310 | 1993 |
| Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015 Y Zhang, WW Yew The International Journal of Tuberculosis and Lung Disease 19 (11), 1276-1289, 2015 | 309 | 2015 |
| Persisters, persistent infections and the Yin–Yang model Y Zhang Emerging microbes & infections 3 (1), 1-10, 2014 | 297 | 2014 |
| Persistent and dormant tubercle bacilli and latent tuberculosis Y Zhang Front Biosci 9 (1-3), 1136-1156, 2004 | 295 | 2004 |
